S-4 Filing

Announced in February, the deal values the merged company at $755 million, which includes a $5 million minimum cash condition to close.

Rose Hill Acquisition in a proxy filing seeks a second deadline extension on its merger with Prize, an exporter of superfruits based in Chile. The latest proposal calls for moving the deadline from July 18 to Jan. 18, 2024. 

At deal announcement in October, terms called for Estrella Biopharma to receive the SPAC’s $45.4 million of cash held in trust at that time. However, ahead of a January extension vote, redemptions erased about 78% from the SPAC’s cash in trust.

Since its public float, the SPAC has been focused on businesses in the Asian market, including China, with an enterprise value between $300 million and $500 million.

The trust currently holds about $120.2 million, according to the proxy. The SPAC raised $258.75 million in a November 2021 IPO.

Acropolis raised $300 million in an IPO nearly two years ago. The SPAC has been focused on companies in infrastructure, infrastructure services and related sectors in North America, though it has yet to announce a deal.

The SPAC in December mutually terminated a $136 million deal with Intrinsic Medicine.

Based in Ireland, Alternus is an international vertically integrated independent power producer. 

The SPAC raised $240 million in an IPO almost two years ago with plans to focus on wireless communications and related technology/product/service businesses.

WinVest raisded $115 million in a September 2021 IPO with plans to target businesses in the financial services industry.